Rilotumumab

DB11972InvestigationalProtein Based Therapies

Rilotumumab has been investigated for the treatment of Cancer, Lung Cancer, Solid Tumors, Gastric Cancer, and Prostate Cancer, among others.

Mechanism
Curator reviewed
Also known as
AMG 102

Resolves to

Compound
UNII51WEW898IJCAS872514-65-3
Targets
P14210HGF

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
420Drug interactionsStructured to mechanism, not free text
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Rilotumumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In